Core Viewpoint - Copper prices are experiencing short-term fluctuations, with expectations of a potential rebound in Q4 due to increased demand from the power grid and air conditioning sectors as trade conflicts ease [3]. Macroeconomic Factors - As of August 1, 2025, SHFE copper closed at 78,400 CNY/ton, down 1.07% from July 25, while LME copper closed at 9,633 USD/ton, down 1.66% [3]. - The U.S. non-farm payrolls for July fell short of expectations, increasing the likelihood of a Federal Reserve rate cut in September, which has weakened the dollar [3]. Supply and Demand - The U.S. has imposed a 50% tariff on imported copper semi-finished products and high-copper-content derivatives starting August 1, excluding electrolytic copper, leading to short-term inventory pressure on LME [3]. - Domestic cable operating rates are lower than the same period last year, and air conditioning production is expected to decline year-on-year from August to October [3]. Inventory Levels - Domestic copper social inventory increased by 4.5% and LME copper inventory rose by 11.2% [4]. - As of August 1, 2025, domestic port copper concentrate inventory stood at 522,000 tons, down 7.0% from the previous week [4]. Raw Material Prices - The price difference between refined copper and scrap copper decreased by 35 CNY/ton this week [5]. - In May 2025, China's refined copper output was 158,000 tons, up 22.7% month-on-month and 11.2% year-on-year [5]. Smelting Production - In July 2025, China's electrolytic copper production was 1.1743 million tons, up 3.5% month-on-month and 14.2% year-on-year [6][7]. Demand Trends - Cable operating rates decreased by 3.5 percentage points, with cable production accounting for 31% of domestic copper demand [8]. - Air conditioning production is projected to decline by 12% year-on-year from August to October [8]. Futures Market - As of August 1, 2025, SHFE copper active contract positions decreased by 5% week-on-week, while COMEX non-commercial net long positions fell by 6% [9].

Group 1: Steel Industry - In July, the PMI for new export orders was reported at 47.10% [4] - The BCI for small and medium enterprises financing environment index in July 2025 was 46.09, a month-on-month decrease of 6.16% [4] - The M1 and M2 growth rate difference in June 2025 was -3.7 percentage points, with a month-on-month increase of 1.9 percentage points [4] Group 2: Non-ferrous Metals - In July, the operating rate of cable enterprises reached a six-year low compared to the same period last year [4] - The copper price is expected to fluctuate in the short term due to lower domestic cable operating rates and a decrease in air conditioning production from August to October [4] - However, tight supply from mines and scrap copper, along with a rebound in demand for power grids and air conditioning in Q4, may lead to an increase in copper prices [4] Group 3: Renewable Energy and Environmental Protection - The political bureau meeting emphasized the importance of promoting a unified national market and optimizing market competition [4] - The "anti-involution" policy is expected to continue, impacting the stock prices of photovoltaic-related companies [4] - Key areas to watch include price-sensitive segments such as silicon materials, glass, and BC batteries [4] Group 4: Pharmaceutical and Biotechnology - The public health emergency response level III was activated in Foshan due to the outbreak of Chikungunya fever, with over 6,000 confirmed cases reported by July 31 [5] Group 5: Company-Specific Developments - New An Co., Ltd. has established a new subsidiary focused on synthetic materials, indicating a strengthened global development strategy [6] - China Shenhua announced plans to acquire assets from the State Energy Group, including coal and related energy assets [6] - TAL Education Group reported a revenue of $575 million for FY26Q1, a year-on-year increase of 38.8%, with net profit significantly exceeding expectations [6]

Core Viewpoint - The company reported strong financial performance in FY26Q1, with significant year-on-year growth in revenue and net profit, indicating robust demand and operational efficiency [3][6]. Group 1: Financial Performance - In FY26Q1, the company achieved revenue of $575 million, a year-on-year increase of 38.8% [3]. - The net profit attributable to shareholders was $31.28 million, reflecting a year-on-year growth of 174.4% [3]. - Non-GAAP net profit reached $42.05 million, up 42.0% year-on-year [3]. Group 2: Learning Services and Other - The offline small class courses remain the largest revenue contributor in the learning services segment, with stable profit margins [4]. - Enrollment in offline small class courses increased year-on-year, with a retention rate of approximately 80% [4]. - Deferred revenue at the end of FY26Q1 was $968 million, showing a year-on-year growth of 50.8%, indicating resilient demand [4]. Group 3: Content Solutions - Learning device revenue continued to grow in FY26Q1, although it saw a quarter-on-quarter decline due to seasonal factors [5]. - The average selling price of learning devices decreased, attributed to changes in product mix, with the launch of three new series [5]. - The overall weekly active rate for learning devices was around 80%, with an average daily usage time of 1 hour per device [5]. Group 4: Profitability Metrics - The company’s gross margin in FY26Q1 was 54.9%, an increase of 3.1 percentage points year-on-year [6]. - The selling expense ratio was 31.4%, up 1.9 percentage points, primarily due to increased online marketing investments [6]. - Non-GAAP operating profit margin was 4.4%, reflecting a year-on-year increase of 4.2 percentage points [6].

Core Viewpoint - The report highlights the current economic indicators and trends in various sectors, including liquidity, infrastructure, real estate, industrial products, and export chains, providing insights into potential investment opportunities and risks. Liquidity - The M1 and M2 growth rate difference was -3.7 percentage points in June 2025, with a month-on-month increase of 1.9 percentage points [4] - The BCI small and medium enterprise financing environment index was 46.09 in July 2025, down 6.16% from the previous month [4] - The London gold spot price increased by 0.79% compared to the previous week [4] Infrastructure and Real Estate Chain - The steel PMI new orders index reached a 9-month high in July [5] - Weekly price changes included rebar down 2.90%, cement price index down 1.37%, rubber down 2.33%, coke up 3.94%, coking coal up 0.98%, and iron ore down 2.55% [5] - National blast furnace capacity utilization rate, cement, asphalt, and all-steel tire operating rates changed by -0.57 percentage points, +0.20 percentage points, +3.0 percentage points, and -3.94 percentage points respectively [5] Real Estate Completion Chain - Titanium dioxide and flat glass prices changed by -0.77% and 0.00% respectively, with flat glass gross profit at -58 CNY/ton and titanium dioxide profit at -1409 CNY/ton [6] - The flat glass operating rate was 75% this week [6] Industrial Products Chain - The PMI new orders index for July was 49.40%, down 0.8 percentage points [7] - Major commodity prices showed cold-rolled down 0.19%, copper down 1.43%, and aluminum down 1.49%, with corresponding gross profit changes of +12.77%, -18.19%, and -10.26% [7] - The national semi-steel tire operating rate was 74.45%, down 1.42 percentage points [7] Subcategories - Tungsten concentrate prices reached a new high since 2011 [8] - Graphite electrode price was 18,000 CNY/ton, unchanged, with a gross profit of 1357.4 CNY/ton, down 10.61% [8] - Electrolytic aluminum price was 20,490 CNY/ton, down 1.49%, with estimated profit at 2926 CNY/ton (excluding tax), down 10.26% [8] Price Comparison Relationships - The price ratio of rebar to iron ore was 4.27 this week [9] - The price difference between hot-rolled and rebar steel was 80 CNY/ton [9] - The price difference between Shanghai cold-rolled and hot-rolled steel reached 390 CNY/ton, up 20 CNY/ton [9] Export Chain - The new export orders PMI for China in July 2025 was 47.10%, down 0.6 percentage points [10] - The China Containerized Freight Index (CCFI) composite index was 1232.29 points this week, down 2.30% [10] - The U.S. crude steel capacity utilization rate was 78.40%, up 0.40 percentage points [10] Valuation Percentiles - The CSI 300 index decreased by 1.75%, with the best-performing cyclical sector being commercial vehicles at -0.51% [11] - The PB ratio of ordinary steel and industrial metals relative to the CSI 300 index was 46.36% and 64.79% respectively [11] - The current PB ratio of the ordinary steel sector relative to the CSI 300 index is 0.57, with the highest value since 2013 being 0.82 [11]

Group 1 - The establishment of Zhejiang Xin'an Yushi Silicon Technology Co., Ltd. with a registered capital of 15 million yuan, focusing on synthetic materials and rubber products sales [4] - The company has a complete industrial chain in the silicon-based new materials sector, covering upstream silicon mining, organic silicon monomer synthesis, and downstream product manufacturing, with an organic silicon monomer capacity of 500,000 tons [5] - The company has the highest self-use terminal conversion rate in the domestic market, exceeding 40%, and offers over 3,000 types of downstream terminal products [5] Group 2 - The company has developed an integrated model for crop protection, covering intermediates, active ingredients, formulations, and agricultural services, providing comprehensive solutions for food security and increased production [7] - The company is a global leader in herbicide varieties, with a production capacity of 80,000 tons for glyphosate and an annual sales capacity of 100,000 tons for active ingredients, achieving a conversion rate of over 70% for active ingredient formulations [7] - The company is expanding its global presence with over 4,500 overseas registration certificates for crop protection products, establishing a marketing network in over 130 countries and regions by 2024 [8]

Market Overview - The pharmaceutical and biotechnology index increased by 2.95%, outperforming the CSI 300 index by 4.70 percentage points and the ChiNext index by 3.23 percentage points, ranking first among 31 sub-industries [4] - The Hong Kong Hang Seng Medical Health Index rose by 1.87%, surpassing the Hang Seng Index by 5.65 percentage points [4] Company R&D Progress Tracking - Recent clinical application submissions include Yimeng Biotech's DB-1419 and Hengrui Medicine's SHR-7782 injection [5] - Haisco's HSK39004 inhalation powder has also initiated its IND application [5] - Ongoing Phase III clinical trials are being conducted for Shiyao Group's SYHX1901 and Hengrui Medicine's SHR-1905, while Hengrui's HRS-7249 is in Phase II, and Kaiyin Technology's KW-040 is in Phase I [5] Current Insights - The outbreak of Chikungunya fever in Foshan has prompted the local government to initiate a Level III public health emergency response, with over 6,000 confirmed cases reported [6] - Several listed companies, including Da'an Gene, Wanfu Biology, and Shengxiang Biology, have developed PCR-based testing solutions for Chikungunya fever [6] - High-throughput sequencing solutions have been introduced by BGI and Dian Diagnostics, while antigen-antibody testing solutions are provided by companies like Aotai Biology and Rejing Biology [6] - This outbreak is expected to accelerate the accumulation of clinical data for related testing products and expedite their market approval [6] 2025 Annual Investment Strategy - The investment strategy emphasizes the need for structural selection of investment opportunities due to complex changes in population structure, policy frameworks, and economic environments [7] - The core contradiction lies in the willingness and ability to pay, leading to a focus on three payment channels within the pharmaceutical industry: hospital payments, out-of-pocket payments, and overseas payments [7] - Key investment directions include policy support for hospital payments (innovative drugs and devices), expansion of public demand (blood products, home medical devices, weight loss drug industry), and an upward cycle for overseas payments (heparin, respiratory joint inspections) [7]

Overall Viewpoint - The article emphasizes the continuation of policies aimed at promoting a unified national market and optimizing market competition, which is expected to have a lasting impact on the solar energy sector. The effectiveness of price support measures and the acceptance of prices by downstream power plants will influence the stock performance of related solar companies, particularly in segments with price elasticity such as silicon materials, glass, and BC batteries [3]. Solar Energy - The political bureau meeting has reiterated the importance of advancing the construction of a unified national market, which is expected to lead to a sustained "anti-involution" policy. The success of price support measures and the implementation of storage plans will be crucial for the stock performance of solar-related companies [3]. Hydropower - The market's understanding of Gas Insulated Lines (GIL) remains low, despite their necessity for interconnecting power stations and high-voltage transmission lines. The investment potential of GIL is significant, comparable to that of traditional hydropower turbines, with the first 550 kV C4 environmentally friendly GIL successfully put into operation by Pinggao Electric [3]. Wind Energy - Progress has been made in the provincial details of Document No. 136, with Shandong province planning its first bidding in August 2025. This is expected to improve bidding data across other provinces. Wind energy will also benefit from the "anti-involution" policy, with a general recovery in the bidding prices for wind turbine units anticipated in the first half of 2025 [3]. Solid-State Batteries - The outlook for solid-state batteries is positive, with a focus on fully solid-state battery equipment and lithium sulfide segments expected to benefit from new tenders initiated by major lithium battery manufacturers. The development of semi-solid batteries and modified electrolytes is also promising, aligning with the "anti-involution" logic and enhancing battery safety and technical standards [4]. Energy Storage - The recent introduction of pricing policies for large-scale electrochemical energy storage in Gansu is expected to counterbalance the gradual elimination of capacity leasing fees, improving the independent storage Internal Rate of Return (IRR). Other provinces are likely to follow suit, and the overall market for energy storage remains robust due to improved commercial models and high demand for energy consumption [4].

本周港口煤价延续上涨，海外油、气价格反弹 查看完整报告 点击注册小程序 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 报告摘要 港口库存显著下降，动力煤价格旺季持续上行 （1）本周秦皇岛港口动力煤平仓价（5500大卡周度平均值）环比+9元/吨（+1.36%），已连续6周维持上行态 势；（2）本周秦皇岛港口煤炭库存522 万吨，环比-10.77%，港口库存迅速下降至同期正常水平（此前持续在 同期最高水平或接近同期最高水平），显示出当前煤炭供需阶段性呈现偏紧局面；（3）在"反内卷"、"查超 产"的背景下，煤炭供需格局有望持续优化，港口煤价有望延续上行态势。 免责声明 本订阅号是光大证券股份有限公司研究所（以下简称"光大证券研究所"）依法设立、独立 运营的官方唯一订阅号。其他任何以光大证券研究所名义注册的、或含有"光 ...

Core Viewpoint - The article highlights the successful clinical trial progress of innovative nuclear medicine developed by Yunnan Baiyao Group, alongside the company's financial performance and strategic initiatives in digital transformation and drug innovation [4][5][6]. Group 1: Financial Performance - In 2024, the company achieved revenue of 40.033 billion, a year-on-year increase of 2.36%; the net profit attributable to the parent company, excluding non-recurring items, was 4.523 billion, up 20.18%, marking a historical high [5]. - The operating cash flow reached 4.297 billion, reflecting a year-on-year growth of 22.68%; the weighted average return on net assets was 11.99%, an increase of 1.48 percentage points year-on-year [5]. - In Q1 2025, the company reported revenue of 10.841 billion, a year-on-year increase of 0.62%, and a net profit of 1.887 billion, up 11.65% [5]. Group 2: Strategic Initiatives - The company is advancing its digital transformation strategy, utilizing data and AI technologies to enhance all aspects of its industrial chain, leading to business innovation and development [5]. - The company is focusing on both traditional Chinese medicine and innovative drugs, with ongoing projects in short, medium, and long-term drug development [6]. - The establishment of the Tianjin R&D platform by the central research institute is expected to facilitate the clinical advancement of multiple nuclear medicine products [6]. Group 3: Drug Development Progress - The company has made significant progress in drug development, with several projects at different clinical trial stages, including the innovative nuclear medicine INR102 injection, which has entered the I/IIa phase [4][6]. - The company is also advancing other drug candidates, such as the JZ-14 capsule for ulcerative colitis, which has been approved for clinical trials [6]. - The introduction of the antibody drug KA-1641 is currently in the preclinical research phase, indicating a broadening of the company's drug portfolio [6].

Macro - The significant downward revision of the U.S. non-farm employment data for June indicates a major impact from tariffs on the U.S. economy, suggesting that the resilience of the economy should not be overestimated, and the direction of interest rate cuts remains clear [5]. Basic Chemicals - The Central Political Bureau emphasized "capacity governance" and "technological innovation," indicating that the domestic chemical industry may benefit from the exit of outdated capacity and the focus on high-performance new materials such as semiconductor materials and OLED materials [5]. Coal Mining - The average price of thermal coal at Qinhuangdao Port increased by 9 CNY/ton (+1.36%) week-on-week, marking six consecutive weeks of price increases. The coal inventory at the port decreased to 5.22 million tons, down 10.77% week-on-week, indicating a tightening supply-demand situation [6][7]. Company Updates - China Merchants Shekou (001979.SZ) has repurchased a total of 44,804,006 shares, accounting for 0.494% of the total share capital, with a total payment of approximately 430.27 million CNY [8]. ARM - ARM's FY26Q1 revenue was $1.053 billion, a year-on-year increase of 12%, but the guidance for FY26Q2 is relatively flat, indicating challenges and opportunities in self-designed chips [8]. Apple - Apple's FY3Q25 results exceeded expectations, showcasing strong resilience due to its core product strength and software ecosystem. However, there is a need for continued focus on AI advancements and tariff pressures [8]. Yunnan Baiyao - Yunnan Baiyao has made significant progress in cost reduction and efficiency enhancement, accelerating the development of innovative nuclear drugs [9].